Warning! GuruFocus detected
1 Severe warning sign
with PYXS.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
New Key Statistics Module, Z-Score and F-Score
NAS:PYXS Key Ratios
Market Cap $ M | 65.29 |
Enterprise Value $ M | -39.60 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.53 |
Price/Sales | 3.37 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 16.00 |
EPS (TTM) $ | -1.29 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -48.20 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.58 |
EV-to-EBITDA | 0.60 |
PEG | -- |
Shares Outstanding M | 61.59 |
Net Margin (%) | -478.95 |
Operating Margin % | -424.23 |
Pre-tax Margin (%) | -492.35 |
Quick Ratio | 7.49 |
Current Ratio | 7.49 |
ROA % (ttm) | -40.49 |
ROE % (ttm) | -51.27 |
ROIC % (ttm) | -142.11 |
Dividend Yield % | -- |
Altman Z-Score | -2.86 |
PYXS Number of Guru Trades
PYXS Volume of Guru Trades
Gurus Latest Trades with NAS:PYXS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PYXS is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pyxis Oncology Inc Insider Transactions
No Available Data
News about NAS:PYXS
Total 0- 1